Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 24, Issue 14, 2010, Pages 2046-2056

  Okano, Masato ^a   Sato, Mitsuhiko ^a   Ikekita, Ayako ^a   Kageyama, Shinji ^a  

^a LSI MEDIENCE CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; BODY FLUIDS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION OF LIQUIDS; MASS SPECTROMETRY; PHASE SEPARATION;

CONTROL PURPOSE; DOPING CONTROL; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE SECRETAGOGUES; GROWTH-PROMOTING EFFECTS; HUMAN URINE; LIQUID CHROMATOGRAPHY ELECTROSPRAY; MASS SPECTROMETRIC IDENTIFICATION; WORLD ANTI-DOPING AGENCY;

METABOLITES;

GROWTH HORMONE-RELEASING PEPTIDE-2; OLIGOPEPTIDE;

ADULT; ELECTROSPRAY MASS SPECTROMETRY; EVALUATION STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; PROCEDURES; URINE; YOUNG ADULT;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; HUMANS; MALE; OLIGOPEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; YOUNG ADULT;

EID: 77954462721     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.4619     Document Type: Article

References (33)

1. Kelly PA, Djiane J, Postel-Vinay MC, Edery M. Endocr. Rev. 1991; 12: 235.
2. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI. Nature 1987; 330: 537.
3. Fuh G, Mulkerrin MG, Wells JA. J. Biol. Chem. 1990; 265: 3111.
4. Bowers CY, Chang J, Momany F, Folkers, K. In Molecular Endocrinology, MacIntyre I, Szelke M (eds). Elsevier: Amster- dam/North Holland, 1977; 287-292.
5. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, Chang K. Endocrinology 1980; 106: 663.
6. Bowers CY, Momany FA, Reynords GA, Hong A. Endocrinology 1984; 114: 1537.
7. Tokunaga T, Hume WE, Umezome T, Okazaki K, Ueki Y, Kumagai K, Hourai S, Nagamine J, Seki H, Taiji M, Noguchi H, Nagata R. J. Med. Chem. 2001; 44: 4641.
8. Smith RG. Endocr. Rev. 2005; 26: 346.
9. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Nature 1999; 402: 656.
10. Blake AD, Smith RG. J. Endocrinol. 1991; 129: 11.
11. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Ander- son J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT. Science 1996; 273: 974.
12. Pong SS, Chaung LY, Dean DC, Nargund RP, Patchet AA, Smith RG. Mol. Endocrinol. 1996; 10: 57.
13. Conn PM, Bowers CY. Science 1996; 273: 923.
14. WADA The 2010 Prohibited List. Available: http:// www.wada-ama.org/Documents/World_Anti-Doping_- Program/WADP-Prohibited-list/WADA_Prohibited_List_ 2010_EN.pdf (accessed 17-03-2010).
15. Holt RIG. Drug Test. Anal. 2009; 1: 412.
16. Laferrère B, Abraham C, Russell CD, Bowers CY. J. Clin. Endocrinol. Metab. 2005; 90: 611.
17. Tivesten A, Bollano E, Caidahl K, Kujacic V, Sun XY, Hedner T, Hjalmarson A, Bengtsson BA, Isgaard J. Endocrinology 2000; 141: 60.
18. Thevis M, Wilkens F, Geyer H, Schanzer W. Rapid Commun. Mass Spectrom. 2006; 20: 3393.
19. Pinyot A, Nikolovski Z, Bosch J, Segura J, Gutièrrez-Gallego R. Anal. Biochem. 2010; 399: 174.
20. Bowers CY. J. Pediatr. Endocrinol. 1993; 6: 21.
21. Doi N, Hirotani C, Ukai K, Shimada O, Okuno T, Kurasaki S, Kiyofuji T, Ikegami R, Futamata M, Nakagawa T, Ase K, Chihara K. Arzneim-Forsch./Drug Res. 2004; 54: 857.
22. Chihara K, Shimatsu A, Hizuka N, Tanaka T, Seino Y, Kato Y. Eur. J. Endocrinol. 2007; 157: 19.
23. Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM. J. Clin. Endocrinol. Metab. 1995; 80: 2987.
24. Pihoker C, Badger TM, Reynolds GA, Bowers CY. J. Endocrinol. 1997; 155: 79.
25. Okano M, Ikekita A, Sato M, Kageyama S. In Recent Advances in Doping Analysis, vol. 16, Schänzer W, Geyer H, Gotzmann A, Mareck U (eds). Sport und Buch Strauß: Cologne, 2008; 223-332.
26. Thomas A, Kohler M, Mester J, Geyer H, Schänzer W, Petrou M, Thevis M. Drug Test. Anal. 2010; 2: 144.
27. Bowers CY, Alster DK, Frentz JM. J. Clin. Endocrinol. Metab. 1992; 74: 292.
28. Geyer H, Parr MK, Koehler K, Mareck U, Schänzer W, Thevis M. J. Mass Spectrom. 2008; 43: 892.
29. Okano M, Sato M, Ikekita A, Kageyama S. Drug Test. Anal. 2009; 1: 518.
30. Nasu R, Kumagai Y, Kogetsu H, Tsujimoto M, Ohtani H, Sawada Y. Drug Metab. Dispos. 2005; 33: 1488.
31. Kaken Pharmaceutical Co., Ltd. Drug Interview Form 2007; 877223.
32. Annesley TM. Clin. Chem. 2003; 49: 1041.
33. Thevis M, Loo JA, Ogorzalek-Loo RR, Schänzer W. Rapid Commun. Mass Spectrom. 2007; 21: 297.